Treatment of Metastatic Breast Carcinoma Refractory to Doxorubicin with Liposomal-Annamycin

Abstract

We studied the toxicity and antitumor activity of Liposomal-Annamycin in patients with metastatic breast carcinoma. Sixteen patients were treated. Toxicity was mild and consisted mostly of bone marrow suppression, particularly granulocytopenia. Non- hematological toxicity was less than what is usually seen with other anthracyclines. No responses were seen.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Oct 01, 2001
Accession Number
ADA411291

Entities

People

  • Aysegul A. Sahin

Organizations

  • The University of Texas MD Anderson Cancer Center

Tags

DTIC Thesaurus Topics

  • Anatomy
  • Biological Sciences
  • Biomedical Research
  • Bone Marrow
  • Bones
  • Breast Cancer
  • Cancer
  • Carcinoma
  • Cell Line
  • Diseases And Disorders
  • Electronic Mail
  • Neoplasms
  • Resistance
  • Skin Diseases
  • Therapy
  • Toxicity

Fields of Study

  • Medicine

Readers

  • Oncology (Cancer Research).